We are live on ! Find out more
GMO

General Moly, Inc.
GMO

Delisted

GMO was delisted on the 30th of September, 2020.

57 hedge funds and large institutions have $27.7M invested in General Moly, Inc. in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more call options, than puts

Call options by funds: $2K | Put options by funds: $2K

11% less funds holding

Funds holding: 6457 (-7)

25% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 20

30% less capital invested

Capital invested by funds: $39.6M → $27.7M (-$11.9M)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
57
Holders Change
-7
Holders Change %
-10.94%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
15
Reduced
20
Closed
12
Calls
$2K
Puts
$2K
Net Calls
Net Calls Change
+$26K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
26
State Board of Administration of Florida Retirement System
Florida
$106K
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$99K -$7.61K -5,300 -7%
Bank of America
28
Bank of America
North Carolina
$62K +$56K +39,017 +581%
NFA
29
Nationwide Fund Advisors
Ohio
$61K
AI
30
ArchPoint Investors
Florida
$59K -$119K -83,231 -66%
BA
31
BlackRock Advisors
Delaware
$55K +$3.14K +2,189 +6%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$52K +$32.5K +22,612 +142%
AIG
33
American International Group
New York
$51.2K -$550 -383 -1%
CS
34
Credit Suisse
Switzerland
$51K +$32.4K +22,570 +148%
Two Sigma Investments
35
Two Sigma Investments
New York
$42K +$44.9K +31,250 New
U
36
UBS
Switzerland
$37K +$19.6K +13,677 +97%
Citigroup
37
Citigroup
New York
$30K +$13.5K +9,428 +72%
CL
38
CSS LLC
Illinois
$29K +$30.9K +21,537 New
ARTA
39
A.R.T. Advisors
New York
$22K
Citadel Advisors
40
Citadel Advisors
Florida
$19K -$2.32K -1,614 -10%
GA
41
Geneva Advisors
Illinois
$18K
Morgan Stanley
42
Morgan Stanley
New York
$18K +$2.82K +1,962 +17%
Deutsche Bank
43
Deutsche Bank
Germany
$15K -$83.3K -58,050 -83%
OC
44
Oppenheimer & Co
New York
$13K
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$13K +$8.59K +5,986 +147%
Invesco
46
Invesco
Georgia
$12K
Wells Fargo
47
Wells Fargo
California
$7K
Barclays
48
Barclays
United Kingdom
$7K +$9.25K +6,445 +1,127%
Group One Trading
49
Group One Trading
Illinois
$4K -$144 -100 -3%
BC
50
Bartlett & Co
Ohio
$3K -$3.59K -2,500 -54%

GMO Hedge Fund Activity: Q4 2013 in Review

57 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in General Moly, Inc. (GMO) for Q4 2013, worth a combined $27.7M — down 30% from $39.6M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of GMO and 5 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 15 added.

The largest buyer was Oxford Asset Management, opening a new position worth an estimated $190K. The largest seller was Coghill Capital Management, cutting an estimated $4.67M.

  • 57 institutional investors held General Moly, Inc. (GMO) as of Q4 2013, down from 64 in Q3 2013.
  • Funds reported $27.7M of General Moly, Inc. stock for Q4 2013, down 30% quarter-over-quarter.
  • 5 funds opened new General Moly, Inc. positions in Q4 2013 and 12 closed out, a net change of -7 holders.
  • The largest General Moly, Inc. buyer in Q4 2013 was Oxford Asset Management, an estimated $190K added.
  • The largest General Moly, Inc. seller in Q4 2013 was Coghill Capital Management, an estimated $4.67M sold.

Based on aggregated 13F filings for Q4 2013.